Technologies

Medical Sciences

Title:

Need for early stage screening platform for Alzheimer's disease

Area:

Medical Sciences

Focus Area:

Frugal Innovation

Status:

Proof of Concept established

Patent:

Filed

Social Benefits:

AI led early stage screening platform for Alzheimers' (taking into account lifecourse risk factors, genetic predisposition and established modalities for AD progression) Outcome: A 3-stage AD risk assessment tool developed.

Developing Agency:

AIZHEIMERS (OPC) Pvt. Ltd., Bangalore

Technology Readiness Index:

TRL 3

Brief Description

Description :

Need for Pre-Emptive Screening Platform for Alzheimers’(AD)

Related Technologies